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ABSTRACT 
Bacterial O-antigens are synthesized on lipid carriers before being transferred to lipopolysaccharide core 
structures. Rhizobium etli CE3 lipopolysaccharide is a model for understanding O-antigen biological function. CE3 
O-antigen structure and genetics are known. However, proposed enzymology for CE3 O-antigen synthesis has 
been examined very little in vitro, and even the sugar added to begin the synthesis is uncertain. A model based 
on mutagenesis studies predicts that 2-acetamido-2,6-dideoxy-d-glucose (QuiNAc) is the first O-antigen sugar 
and that genes wreV, wreQ and wreU direct QuiNAc synthesis and O-antigen initiation. Previously, synthesis of 
UDP-QuiNAc was shown to occur in vitro with a WreV orthologue (4,6-hexose dehydratase) and WreQ (4-
reductase), but the WreQ catalysis in this conventional deoxyhexose-synthesis pathway was very slow. This 
seeming deficiency was explained in the present study after WreU transferase activity was examined in vitro. 
Results fit the prediction that WreU transfers sugar-1-phosphate to bactoprenyl phosphate (BpP) to initiate O-
antigen synthesis. Interestingly, WreU demonstrated much higher activity using the product of the WreV 
catalysis [UDP-4-keto-6-deoxy-GlcNAc (UDP-KdgNAc)] as the sugar-phosphate donor than using UDP-QuiNAc. 
Furthermore, the WreQ catalysis with WreU-generated BpPP-KdgNAc as the substrate was orders of magnitude 
faster than with UDP-KdgNAc. The inferred product BpPP-QuiNAc reacted as an acceptor substrate in an in vitro 
assay for addition of the second O-antigen sugar, mannose. These results imply a novel pathway for 6-
deoxyhexose synthesis that may be commonly utilized by bacteria when QuiNAc is the first sugar of a 
polysaccharide or oligosaccharide repeat unit: UDP-GlcNAc → UDP-KdgNAc → BpPP-KdgNAc → BpPP-QuiNAc. 
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ABBREVIATIONS  
BpP, bactoprenyl phosphate; BpPP, bactoprenyl pyrophosphate; DGK, kinase encoded by Streptococcus mutans 
dgk, with preference for polyprenol substrates; GlcNAc, 2-acetamido-2-deoxy-d-glucose, also known as N-acetyl-
d-glucosamine; GT, glycosyltransferase; KdgNAc, 2-acetamido-2,6-dideoxy-d-xylo-4-hexulose, also known as 4-
keto-6-deoxy-GlcNAc; LPS, lipopolysaccharide; Man, mannose; QuiNAc, 2-acetamido-2,6-dideoxy-d-glucose, also 
known as N-acetyl-d-quinovosamine; Und-P, undecaprenyl phosphate; Und-PP, undecaprenyl pyrophosphate.  
INTRODUCTION  
O polysaccharide, or O-antigen, is the outermost component of the lipopolysaccharide (LPS) that is the major 
constituent of the outer leaflet of the outer membrane in bacteria [ 1 ]. Bacterial mutants lacking O-antigen have 
deficiencies that reveal the profound physiological and ecological importance of this portion of LPS [ 2–8 ]. For 
instance, complete and abundant O-antigen ( Fig. 1a ) of the model bacterium of this study, Rhizobium etli strain 
CE3, is indispensable for infection and development of nitrogen-fixing root nodules on its legume host, 
Phaseolus vulgaris [ 9–11 ].  
 
 
Fig. 1.  
(a) Structure of Rhizobium etli CE3 O-antigen. The O-antigen structure of R. etli LPS is shown linked to the lipid A 
core. Abbreviations for the sugars: QuiNAc, N-acetyl- d-quinovosamine; Man, mannose; Fuc, fucose; MeGlcA, 
methyl-glucuronate; 3OMe6dTal, 3-O-methyl-6-deoxytalose; terminal residue, TOMFuc, 2,3,4-tri-O-
methylfucose or DOMFuc, 2,3-di-O-methylfucose. The proposed first O-antigen sugar, QuiNAc, is highlighted. (b) 
R. etli CE3 O-antigen genetic clusters. Upper panel: the chromosomal wre gene cluster (previously called lps 
region α) spanning nucleotides 784 527 to 812 262 of the genome sequence consists of 25 predicted ORFs. 
Another chromosomal ORF ( wreQ) spanning nucleotides 2 969 313 to 2 970 242 is required for QuiNAc synthesis 
[ 27 ]. Lower panel: a 4-kilobase cluster on plasmid pCFN42b consists of three predicted ORFs. In each panel the 
predicted GTase-encoding genes are in grey. Genes encoding enzymes studied in the current work, wreG, wreQ, 
wreU and wreV, are specifically labelled. (c) Two hypotheses of O-antigen initiation in R. etli CE3. Reactions in 
each hypothesis and the enzyme that catalyses each reaction are indicated. In both hypotheses, the first 
reaction (1) is the same, the conversion of UDP-GlcNAc to UDP-KdgNAc catalysed by the predicted 4,6-
dehydratase WreV. The two hypotheses differ in reactions (2) and (3). In hypothesis 1, KdgNAc is reduced to 
QuiNAc on the UDP linkage by WreQ and then QuiNAc-1-P is transferred by WreU. In hypothesis 2, KdgNAc-1-P 
is transferred by WreU first and then KdgNAc is reduced to QuiNAc by WreQ on the Und-PP linkage.  
 
The CE3 O-antigen is also an intriguing model for studying polysaccharide biosynthesis. It has features, such as 
its precisely controlled number of repeat units [ 12 ], which are not readily explained by known mechanisms. 
Making it attractive is also the fact that all 29 genes considered necessary specifically for its synthesis have been 
mutated. For instance, it has been possible to identify nine genes encoding glycosyltransferases (GTs), and, by 
biochemical analysis of truncated LPS from each GT mutant, to explain which sugar linkages are catalysed by 
each of the nine GTs [ 13 ] ( Fig. 1b ). However, these assignments have not been confirmed by investigation in 
vitro with purified enzymes and defined substrates. The initial step of the biosynthesis is a logical first reaction 
to investigate.  
 
The biosynthesis of all characterized O-antigens is believed to share a conserved initial type of reaction catalysed 
by a family of GTs that are integral membrane proteins. The initiating GTs catalyse transfer of a sugar-1-
phosphate moiety from a nucleotide-sugar donor to the membrane lipid carrier bactoprenyl phosphate (BpP), 
resulting in bactoprenyl-pyrophosphoryl-sugar (BpPP-sugar) [ 14, 15 ]. Due to the difficulty in obtaining purified 
enzymes and the limited availability of substrates, this initial step in the synthesis of an O-antigen has been 
demonstrated in only a few cases [ 16–18 ]. In R. etli CE3 O-antigen ( Fig. 1a ), the proposed first sugar is 2-
acetamido-2,6-dideoxy- d-glucose ( d-QuiNAc, hereafter referred to as QuiNAc) [ 12, 13, 19 ]. Although QuiNAc is 
found in a number of bacterial polysaccharides, the mechanism of its incorporation into a polysaccharide, in 
particular as the initiating sugar, has not been reported. The predicted initiating GT for R. etli CE3 O-antigen 
synthesis is encoded by the wreU gene ( Fig. 1b ) [ 13 ]. The LPS of a wreU null mutant lacks all O-antigen-specific 
sugars including QuiNAc [ 13 ].  
 
QuiNAc is derived from the central metabolite UDP-GlcNAc (UDP- N-acetyl- d-glucosamine [UDP-2-acetamido-2-
deoxy- d-glucose]) [ 19, 20 ]. Besides WreU, two additional enzyme activities are expected in a pathway from 
UDP-GlcNAc to BpPP-QuiNAc ( Fig. 1c ). The first is a 4,6-dehydratase that catalyses conversion of UDP-GlcNAc to 
UDP-2-acetamido-2,6-dideoxy- d-xylo-4-hexulose (also known as UDP-4-keto-6-deoxyGlcNAc and hereafter 
referred to as UDP-KdgNAc). R. etli gene wreV ( Fig. 1b ) encodes a protein whose predicted sequence aligns 
with enzymes known to catalyse this reaction in vitro [ 19, 21–25 ]. The gene for one of these characterized 
enzymes, Pseudomonas aeruginosa wbpM, complements R. etli wreV mutants [ 19 ].  
 
The other expected enzyme activity is a 4-reductase that catalyses the reduction of the KdgNAc moiety to 
QuiNAc ( Fig. 1c ). Analysis of the R. etli CFN42 total nucleotide sequence assigns this type of activity to the 
protein encoded by wreQ ( Fig. 1b ), and mutation of this gene has previously been shown to cause the absence 
of QuiNAc from the R. etli CE3 LPS [ 26 ]. Recently, it was shown that WreQ catalyses the conversion of UDP-
KdgNAc to UDP-QuiNAc in vitro [ 19 ]. However, the catalysis by WreQ was relatively very slow, raising the 
question of whether UDP-KdgNAc is the natural substrate of WreQ in vivo. Also relevant is the fact that in the 
small amount of LPS O-antigen produced by a wreQ null mutant, the QuiNAc residue is replaced by KdgNAc [ 27 
]. This result raises the possibility that WreU acts on either the QuiNAc or KdgNAc moiety, or, considering the 
observed slow WreQ catalysis with UDP-KdgNAc as the substrate, the normal route to QuiNAc in vivo may be the 
one shown in Fig. 1(c) as hypothesis 2.  
In the present study, the alternative hypothetical pathways of Fig. 1(c) were tested by an in vitro biochemical 
approach using enzymes expressed from hybrid cloned genes in Escherichia coli. In addition, BpPP-QuiNAc was 
shown to be a functional acceptor substrate for the next step in CE3 O-antigen synthesis in an assay in vitro 
using the predicted sugar donor and the predicted transferase encoded by gene wreG.  
RESULTS  
Recombinant R. etli WreU was expressed in E. coli  
The wreU gene of R. etli CE3 was cloned into a pET15b vector, yielding a genetic construct from which the 
expressed WreU protein included an amino-terminal six-histidine (His 6) tag. When this ORF was subcloned into 
a vector that replicates in R. etli, its expression complemented the LPS-deficient phenotype of R. etli wreU-null 
mutant strain CE566 (Fig. S1, available with the online version of this article). After overexpression in E. coli, His 
6-WreU was found exclusively in the cell membrane fraction. Attempts to purify His 6-WreU free of membrane 
were not successful despite trying various detergents, various expression conditions, and making other types of 
WreU constructs. Thus, the E. coli membrane fraction containing His 6-WreU was used in the in vitro studies of 
WreU.  
 
WreU possessed GT activity with preference for UDP-KdgNAc as the nucleotide-sugar 
substrate  
For testing WreU enzymatic activity, the lipid carrier substrate, undecaprenyl phosphate (Und-P), was 
synthesized in situ from undecaprenol and ATP with an enzyme having polyprenol kinase activity as described by 
[ 28 ]. UDP-KdgNAc or UDP-QuiNAc, each enzymatically synthesized as described previously [ 19 ], or UDP-
GlcNAc was added as a possible nucleotide-sugar substrate. The reactions were started by adding WreU-
containing membranes, or control membranes lacking WreU, and terminated by chloroform-methanol 
extraction. Und-PP-sugars, such as the predicted products of WreU catalysis, partition into the organic phase in 
this type of extraction thereby separating them from the nucleotide-sugar substrates [ 29, 30 ].  
 
To facilitate visualization of the product after TLC separation, the lipid substrate Und-P was labelled with 32P by 
using ATP (γ- 32P) in its synthesis. The result of the WreU assay is shown in Fig. 2 . An abundant product 
corresponding to an undecaprenyl pyrophosphate-linked sugar (Und-PP-sugar) candidate (compound I) was 
detected in the reaction only with UDP-KdgNAc as the nucleotide-sugar substrate ( Fig. 2 , lane 4). In the 
reaction with an equal concentration of UDP-QuiNAc, a faint spot representing a different Und-PP-sugar 
candidate (compound II) was observed ( Fig. 2 , lane 5), and no product was detected in the reaction with UDP-
GlcNAc ( Fig. 2 , lane 3). When quantified with a phosphorimager, compound I in lane 4 had a 30-fold higher 
intensity than compound II in lane 5. Importantly, the production of compounds I and II required both the lipid 
substrate Und-P and the enzyme WreU ( Fig. 2 , lane 1, 2). These results provided evidence that WreU is an 
initiating GT and UDP-KdgNAc is the preferred sugar-P-donor substrate. UDP-QuiNAc was much less favoured, 
and UDP-GlcNAc led to no detectable reaction.  
 
 
 
Fig. 2.  
Nucleotide sugar substrate specificity of R. etli WreU and TLC analysis of the products of its activity. The images 
show TLC separation of products extracted into the organic phase after generation in WreU reactions that 
included 32P-labelled lipid substrate Und-P. Two portions of one autoradiogram from one experiment are shown. 
Lanes: lane 1, by omitting the polyprenyl kinase for its synthesis, lipid substrate Und-P was absent (negative 
control 1); lane 2, no WreU crude enzyme was added to the reaction (negative control 2); lanes 3–5, different 
nucleotide sugar substrates were added, as indicated in the table above the TLC images. Inferred compounds: I, 
Und-PP-KdgNAc; II, Und-PP-QuiNAc; *, a compound derived from Und-P in the presence of E. coli membrane (its 
Rf value with a different TLC solvent (not shown) matches that of Und-PP [ 44 ]).  
 
WreQ catalysed the reduction of KdgNAc to QuiNAc on Und-PP linkage  
The foregoing results with WreU were consistent with the second step of hypothesis 2 ( Fig. 1c ). Hence, the next 
step of this hypothesis was tested: does WreQ catalyse the reduction of Und-PP-KdgNAc to Und-PP-QuiNAc? His 
6-WreQ had been produced and purified in a previous study, in which it had been shown to catalyse the 
reduction of d-KdgNAc stereospecifically to d-QuiNAc [ 19 ].  
 
A WreU-WreQ-coupled assay was carried out with 32P-radiolabelling ( Fig. 3 ). The Und- 32PP-KdgNAc (compound 
I) produced in the WreU reaction ( Fig. 3 , lane 1) served as a substrate for WreQ. NADH was chosen as the 
reducing substrate. When both WreQ and NADH were added to the WreU reaction mixture, compound I was 
completely converted to a faster-moving compound (compound II) ( Fig. 3 , lane 4). When NADH alone was 
added without WreQ, no conversion occurred ( Fig. 3 , lane 3). When WreQ was added but NADH was omitted, a 
very small amount of compound II was produced ( Fig. 3 , lane 2), possibly due to contaminating NADH from the 
crude WreU enzyme (membrane).  
 
 Fig. 3.  
Alteration of WreU reaction product by addition of WreQ and NADH. The autoradiogram shows TLC separation 
of products extracted into the organic phase after generation in WreU-WreQ-coupled enzyme assays. All 
reactions were set up as noted for lane 4 of Fig. 2 , with UDP-KdgNAc as the nucleotide substrate for WreU, and 
the reactions were allowed to proceed for 1 h. The reactions then varied by whether WreQ and NADH were 
added at this point, and incubation continued for another hour. Lanes: lane 1, WreU reaction only; lane 2, WreQ 
added to the WreU reaction; lane 3, NADH added to the WreU reaction; lane 4, both WreQ and NADH added to 
the WreU reaction. Inferred compounds: I, Und-PP-KdgNAc; II, Und-PP-QuiNAc; *, Und-PP (see Fig. 2 legend).  
 
WreQ catalysis was much faster when KdgNAc was linked to Und-PP rather than UDP  
The result of the WreU-WreQ-coupled assay suggested that WreQ has Und-PP-KdgNAc (compound I) reductase 
activity, leading to Und-PP-QuiNAc (compound II) as the product. WreQ can also catalyse UDP-KdgNAc reduction 
to UDP-QuiNAc in vitro, but that reaction is relatively slow [ 19 ]. The rates of catalysis with Und-PP-KdgNAc as 
the substrate versus UDP-KdgNAc as the substrate were compared by TLC and autoradiography in the following 
experiments.  
 
To provide conditions for estimating the rate of a WreQ-catalysed reduction of the lipidated substrate Und-PP-
KdgNAc, the WreU-WreQ-coupled reactions were performed with serially diluted WreQ concentrations, and the 
WreQ reaction was allowed to proceed for only 1 min (instead of 1 h in the experiment shown in Fig. 3 ). The 
conversion of Und-PP-KdgNAc (compound I) to Und-PP-QuiNAc (compound II) gradually increased with 
decreasing dilution of WreQ (from 10 −6 to 10 −2) ( Fig. 4a , lanes 2–6). The negative control (0 min) indicated that 
the method to stop the reaction was effective ( Fig. 4a , lane 1). At 10 −2 dilution, the conversion was almost 
complete in 1 min ( Fig. 4a , lane 6), whereas the reactions with 10 −3 and 10 −4 diluted WreQ enzyme were slow 
enough that reaction rates/enzyme concentration (V/[E]) could be estimated ( Table 1 ).  
 
  
Fig. 4.  
Comparison of the WreQ kinetic activity with lipid-linked versus nucleotide-linked substrates. Autoradiograms 
show products separated on TLCs after controlled times of incubation and concentrations of WreQ. (a) WreQ 
catalysis with the lipidated substrate. First, [ 32P] WreU transferase reactions with the UDP-KdgNAc substrate 
were allowed to proceed for 1 h (i.e. under the same conditions as for Fig. 2 , lane 4). Then, WreQ and NADH 
were added. After 1 min, the reactions were terminated by adding and rapidly mixing with chloroform-
methnol/3 : 2 (solvent I). Lanes: lane 1 is a 0 min control in which solvent I was added before WreQ; lanes 2–8 
are groups that contain serially diluted WreQ, from 10 6 to 1 (undiluted). Inferred compounds: I, Und-PP-
KdgNAc; II, Und-PP-QuiNAc. (b) WreQ catalysis with UDP-KdgNAc. WreQ and NADH were added to reactions in 
which UDP-[ 3H]KdgNAc was produced by complete conversion from UDP-[ 3H]GlcNAc catalysed by WbpM in a 
30 min reaction [ 19 ]. WreQ concentration was the same as the undiluted concentration used in panel (a) (10 µg 
His 6-WreQ per 100 µl reaction). Catalysis was allowed to proceed for different times before being terminated by 
boiling. Lanes: lane 1, 0 min; lane 2, 1 min; lane 3, 5 min; lane 4, 30 min.  
 
Table 1. Comparing the estimated enzymatic activities of WreQ with the two substrates, UDP-KdgNAc and Und-
PP-KdgNAc  
 
Substrate Substrate 
concentration 
[S] (µM) 
WreQ 
concentration 
[E] (µM) 
Substrate 
conversion 
(%) 
Product 
concentration 
[P] (µM) 
Reaction 
time t 
(min) 
Reaction 
rate 
V=[P]/t 
(µM 
min−1) 
Substrate 
conversion 
per active 
site per 
min  
 
V/[E] 
(min−1) 
UDP-
KdgNAc 
500 28 45 225 30 7.5 0.27 
Und-PP-
KdgNAc 
0.33 0.0028 62.5 0.206 1 0.206 74 
 
0.3 0.00028 14 0.042 1 0.042 150 
Substrate conversion was calculated from the TLC result shown in Fig. 4 . The intensities of spots were measured 
by ImageQuantTL software for 32P spots in Fig. 4(a) and by ImageJ software for 3H spots in Fig. 4(b) .  
 
For visual comparison, the WreQ catalysis with the nucleotide substrate UDP-KdgNAc was carried out with a 
single (much higher) WreQ concentration and terminated at different time points ( Fig. 4b ). The reaction 
showed near linear progression and the data obtained at 30 min reaction time ( Fig. 4b , lane 2) was used for 
calculation of the reaction rate ( Table 1 ). The V/[ E] calculated from the results in Fig. 4 indicated that the 
WreQ catalysis was at least two orders of magnitude faster when KdgNAc was linked to Und-PP rather than UDP 
( Table 1 ), even though the lipidated substrate was presented at 1000-fold lower concentration.  
 
WreG catalysed the addition of the second O-antigen sugar (mannose) to Und-PP-
QuiNAc  
A previous study based on mutant phenotypes proposed that WreG is the GT that transfers the second O-
antigen sugar mannose (Man) to QuiNAc [ 13 ]. The in vitro assay system developed in the present study 
provided a means to obtain biochemical evidence for the role of WreG and to confirm that Und-PP-QuiNAc is 
the precursor for further O-antigen synthesis. As a first step, the wreG gene of R. etli CE3 was cloned into vector 
pET21b such that the expressed WreG protein in E. coli included a carboxy-terminal His 6 tag. When this ORF was 
subcloned into a vector that replicates in R. etli, its expression complemented the LPS-deficient phenotype of R. 
etli wreG-null mutant strain CE358 (Fig. S2). To test the enzymatic activity of WreG-His 6, two potential acceptor 
substrates, Und-PP-KdgNAc (compound I) and Und-PP-QuiNAc (compound II), were produced by the WreU 
reaction and the WreU-WreQ-coupled reaction, respectively ( Fig. 5 , lanes 2 and 3). GDP-Man was added as the 
donor of Man, and WreG was added as a crude membrane fraction ( Fig. 5 , lanes 4 and 5) or as purified enzyme 
( Fig. 5 , lane 6).  
 
  
Fig. 5.  
The product generated by the combined action of WreU, WreQ and predicted Bp-PP-QuiNAc mannosyl 
transferase WreG. 32P-labelled compounds were extracted into the organic phase after reactions with six varied 
combinations of WreU, WreQ, WreG and substrates. The two panels show autoradiograms of TLCs carried out 
with two different solvents, 2-propanol/ammonium hydroxide/water, 6 : 3 : 1 (a) and 
chloroform/methanol/water, 65 : 25 : 4 (b). All reaction mixtures contained substrates UDP-KdgNAc, Und- 32P and 
GDP-Man. They varied by lacking added NADH or enzyme as follows: lane 1, no WreU; lane 2, no WreQ, WreG or 
NADH; lane 3, no WreG; lane 4, no WreQ or NADH; lane 5, WreG activity provided by crude membrane fraction 
and all other reagents and enzymes added; lane 6, all reagents and enzymes added, including purified WreG 
enzyme. Inferred compounds: I, Und-PP-KdgNAc; compound II, Und-PP-QuiNAc; compound III, Und-PP-QuiNAc-
Man; *, Und-PP (see Fig. 2 legend).  
 
Und-PP-KdgNAc (compound I) remained almost unchanged when crude WreG and GDP-Man were included in 
the WreU reaction (compare lane 4 to lane 2 in Fig. 5 ). In contrast, the Und-PP-QuiNAc (compound II) produced 
when WreQ was added to the WreU reaction mixture was converted to a slower-moving compound (compound 
III) when WreG and GDP-Man were also added (as shown by lanes 5 and 6 compared to lane 3 in Fig. 5 ). When 
WreG was added as a crude membrane preparation, compound II was almost completely replaced by compound 
III ( Fig. 5 , lane 5), whereas the purified WreG was less active, as revealed by partial conversion of compound II 
to compound III in lane 6 of Fig. 5 .  
 
Based on the substrate requirements for its formation, compound III was inferred to be Und-PP-QuiNAc-Man, 
the predicted lipid-linked disaccharide resulting from the GT activity of WreG. Because compound III migration 
was nearly identical to Und-P in TLC solvent A ( Fig. 5 a), a different solvent (solvent B) was also used. This 
second solvent system separated compound III from Und-P and other radiolabelled compounds ( Fig. 5 b).  
 
The result of this assay provided in vitro evidence that WreG is the mannosyltransferase for adding the second 
O-antigen sugar (Man) in R. etli CE3. Furthermore, Und-PP-QuiNAc was utilized much more readily than Und-PP-
KdgNAc as the acceptor of Man in vitro, suggesting that normally the reduction of KdgNAc to QuiNAc by WreQ 
would occur before Man addition.  
 
DISCUSSION  
Results in this study lead to the following inferences regarding QuiNAc and O-antigen synthesis in R. etli, as 
discussed further in succeeding paragraphs: (1) the conversion of d-GlcNAc to d-QuiNAc in R. etli occurs in an 
unconventional manner compared with other characterized deoxysugar syntheses (i.e. it follows hypothesis 2 of 
Fig. 1c ). As with biosynthesis of other 6-deoxysugars, it proceeds with formation of a 4-keto-6-deoxyhexose 
intermediate (KdgNAc). However, the KdgNAc-P intermediate is first transferred from nucleotide linkage to a 
bactoprenyl phosphate carrier before undergoing 4-reduction to the 6-deoxy product, QuiNAc. (2) The switch 
from nucleotide linkage to lipid carrier is directed by WreU, whose reaction requirements confirm the prediction 
that it is the initiating GT for R. etli O-antigen biosynthesis. The specificity of WreU for KdgNAc dictates that 
bactoprenyl-PP-KdgNAc is the first lipid-linked O-antigen intermediate. (3) The unconventional lipidated-
substrate specificity of 4-reductase WreQ is responsible for delaying conversion of KdgNAc to QuiNAc until 
KdgNAc is attached to bactoprenol-PP. Without WreQ, KdgNAc would be the predicted proximal sugar of the 
final O-antigen, and, in fact such is the case in the small amount of O-antigen produced in wreQ-null mutant 
strain CE166 [ 27 ]. (4) The acceptor-substrate specificity of mannosyltransferase WreG ensures that QuiNAc 
predominately replaces KdgNAc before O-antigen synthesis can proceed. WreG operates fastest with 
bactoprenyl-PP-QuiNAc and thereby dictates that QuiNAc and WreQ are needed for efficient synthesis of the R. 
etli CE3 O-antigen.  
 
WreU is a UDP-KdgNAc:bactoprenyl-P KdgNAc-1-P transferase (reaction 2 of hypothesis 2 in Fig. 1c). This 
conclusion is based on (1) the substrate requirements of the reaction it catalyses, (2) physical and chemical 
properties of the inferred product, and (3) the degree of sequence alignment with other characterized initiating 
GTs. The lipid substrate of WreU in the in vitro reactions was undecaprenyl phosphate (Und-P or C 55-P). 
However, the exact form of bactoprenol lipid carrier in R. etli CE3 is not known. It is likely dodecaprenol-P (C 60-
P) as reported for Rhizobium leguminosarum 3841 and Sinorhizhobium meliloti 1021 [ 31 ]. Of the two 
hypothetical sugar-donor substrates ( Fig. 1c , hypothesis 1 vs hypothesis 2), UDP-KdgNAc yielded 30-fold 
greater activity than UDP-QuiNAc in vitro. The lack of activity with UDP-GlcNAc as the donor substrate indicates 
that WreU requires the 6-deoxy moiety for activity. The products, compounds I (from UDP-KdgNAc) and II (from 
UDP-QuiNAc), behaved in solvent extraction and relative TLC migration as would be predicted. They also carried 
the input 32P of the lipid substrate. The WreU enzyme assay was also carried out with different radioisotope 
labelling in which the UDP-KdgNAc carried tritium [ 3H] in the sugar moiety. After extraction into the organic 
solvent, the 3H-labelled product showed the same relative migration on TLC as the 32P-compound I (data not 
shown). Hence, radiolabelling provided additional evidence of both the input lipid and the sugar being present in 
the product.  
 
A final argument for the enzymatic identity of WreU is based on the predicted amino-acid sequence of 
translated wreU. The predicted topology and sequence alignment of WreU (Fig. S3) places it within a large 
subgroup of the superfamily of initiating GTs represented by the active carboxy-terminal portion of Salmonella 
WbaP [ 18 ], WecP from Aeromonas hydrophila AH-3 [ 17 ], and PglC from Campylobacter jejuni NCTC 11168 [ 32 
]. Like other members of this subgroup, WreU is predicted to have a single transmembrane segment near the 
amino-terminus followed by a cytoplasmic catalytic domain that constitutes the rest of the polypeptide of these 
‘small’ phospho-GTs [ 33 ].  
 
WreQ catalysed the inferred 4-reduction of KdgNAc to QuiNAc orders of magnitude faster when KdgNAc was 
attached to Und-PP than when it was attached to UDP. The very slow reduction of UDP-KdgNAc by the WreQ 
catalysis reported in a previous study [ 19 ] is thereby explained. The study of that slower reaction, however, had 
the advantage that it was chemically very clean and allowed definitive demonstration that the QuiNAc produced 
by the WreQ catalysis has the d-stereo configuration [ 19 ].  
 
Although this may be the first report of 6-deoxyhexose biosynthesized in this way, a conceptually analogous 
precedent is N-acetylgalactosamine (GalNAc) synthesis in E. coli by the Gnu pathway, in which the WecA-
initiating GT first transfers GlcNAc-1-P to Und-P and the Und-PP-GlcNAc product is converted to Und-PP-GalNAc 
via a Gnu epimerase [ 34, 35 ]. The overall outcome is to generate a primer for synthesis of a polysaccharide or 
oligosaccharide repeat that will have GalNAc at its reducing terminus. This is exactly analogous to the apparent 
metabolic role of the WreV-WreU-WreQ pathway and its product bactoprenyl-PP-QuiNAc in R. etli.  
 
Another pathway for d-QuiNAc synthesis was reported recently [ 20 ]. It proceeds by the first two steps as 
outlined in hypothesis 1 of Fig. 1c , i.e. the path not followed by WreV-WreU-WreQ in R. etli. Discovered in 
Bacillus cereus strain ATCC 14579, it is catalysed by a 4,6-dehydratase and a 4-reductase that are not 
homologous with WreV and WreQ [ 20 ]. Whereas the bactoprenyl-P-coupled pathway of the Proteobacteria 
seems suited to provide QuiNAc only to begin polysaccharides and oligosaccharide repeat units, this pathway in 
the bacilli conceivably could be used to provide QuiNAc either for interior glycosyl positions or the initial 
position in a growing chain. Surprisingly, though, this more conventional pathway may be very limited 
phylogenetically. The 4-reductase, Preq, shows high sequence similarity only with proteins in other bacilli and 
perhaps certain closely related firmicutes. An extensive database search did not find it in Proteobacteria, where 
the bactoprenyl-P-coupled pathway catalysed by WreV-WreU-WreQ orthologues is widely distributed (Table S1).  
 
Results obtained with WreG validated the functionality of the in vitro product of WreU and WreQ activity for 
CE3 O-antigen synthesis. Based on its structure and the responsible wre genes, the CE3 O-antigen synthesis has 
been deduced [ 13 ] to follow the lesser known of the two common overall mechanisms of O-antigen synthesis [ 
1 ], in which the complete O-antigen with all repeat units is made on the cytoplasmic face of the inner 
membrane and then transported across the membrane. The model for CE3 O-antigen [ 13 ] proposes that 
QuiNAc is the primer residue [ 1, 36 ] for the remainder of O-antigen synthesis, with Man being the next 
‘adaptor’ sugar added ( Fig. 1a ). WreG is the predicted transferase that catalyses this addition and GDP-Man is 
the donor substrate for Man addition. The results of the in vitro assay of WreG activity ( Fig. 5 ) supported both 
predictions of the model and Und-PP-QuiNAc as the product from the WreU and WreQ catalysis. The existence 
of WreQ and the specificity of WreG are coupled. Selectivity for the 4-OH of QuiNAc by WreG [i.e. much slower 
catalysis with bactoprenyl-PP-KdgNAc ( Fig. 5 )] is the key reason that WreQ-null mutants have low abundance of 
O-antigen [ 26 ]. However, WreG in vivo apparently has enough activity with KdgNAc as the Man acceptor that 
such mutants have a low amount of O-antigen that is identical to the normal O-antigen except for substitution of 
KdgNAc for QuiNAc [ 27 ]. A faint spot visible in lane 4 of Fig. 5 , (circled in Fig. S4a) may be due to this lower 
activity of WreG with Und-PP-KdgNAc as the acceptor substrate in vitro. This logic leads to the prediction that 
greatly increasing the specific concentration of just the WreG enzyme will lead to higher O-antigen production in 
a wreQ-minus genetic background. Fig. S4(b) shows results that confirm this prediction. This result explains the 
basis of the genetic suppression of the WreQ-minus phenotype by multiple copies of the main wre cluster [ 26 ]. 
Importantly, it also supports hypothesis 2 over hypothesis 1 of Fig. 1(c ) by means of in vivo results that are 
independent of the in vitro assays.  
 
The phylogenetic distribution of this pathway of QuiNAc synthesis was investigated by blast searches of the 
sequenced protein database (Table S1). At least 40 genera had at least one strain that carried orthologues of all 
three genes– wreV, wreU and wreQ. Two genera of green-sulfur bacteria had strong matches, but almost all of 
the rest were in the Proteobacteriaceae, with all its subphyla being represented (Table S1). blast e-values were 
less than e −30 for all three homologues in all strains.  
 
It should be noted that WreQ orthologues are the genes needed specifically for QuiNAc synthesis by the 
bactoprenyl pathway. As stated above, WreV-WreQ are often linked with WreU orthologues, but, at lower 
frequency, they are found with orthologues of WbpL, another initiating GT. In a limited search of WreQ hits with 
e-values below e −89, 211 were linked to a WreU homologue (Table S1) and 63 to a WbpL homologue (Table S2). 
WreU and WbpL are not homologous; they represent the two very different types of initiating GT structures. It is 
reasonable to suppose that other initiating GT subtypes are coupled with WreVQ in a strain, depending on how 
the genetic cluster has evolved.  
 
Recently, Colwellia psychrerythraea 34 h, was found to make an ‘antifreeze’ polysaccharide that has a repeat 
unit containing QuiNAc [ 37 ]. Its ability to synthesize QuiNAc had been predicted the previous year [ 19 ] 
because it had WreV and WreQ sequence matches with very low e-values. A gene whose encoded protein has a 
significant match with WreU is adjacent to the wreQ orthologue on the genome, and the wreV orthologue is 
separated by three genes (Fig. S5).  
 
In summary, results in this study strongly support the second of the two alternative hypotheses of Fig. 1(c ). A 
main conclusion is that biosynthesis of QuiNAc in R. etli CE3 (and probably in many other bacteria) is tightly 
coupled to initiation of the synthesis of a polysaccharide on which it is ultimately the first (reducing-end) sugar. 
Fig. 6 depicts this coupling, the steps in the pathway, and its association with the membrane. Phylogenomic 
searches suggest that this pathway is distributed widely among the Proteobacteria. The outcome is Bp-PP-
QuiNAc, which in R. etli CE3 becomes the platform for the rest of O-antigen synthesis, the next step of which 
was also demonstrated in this study and is depicted in Fig. 6 as well.  
 
 
Fig. 6.  
Model of QuiNAc synthesis coordinated with O-antigen initiation. The three phases of QuiNAc synthesis in R. etli 
CE3 are indicated with numbers: first, UDP-GlcNAc is converted to intermediate UDP-KdgNAc by the 
dehydratase WreV (phase 1); second, KdgNAc-1-P is transferred by WreU to the bactoprenyl phosphate (BpP) 
lipid carrier (phase 2); third and last, the KdgNAc moiety is reduced to QuiNAc by WreQ (phase 3). The final 
product of QuiNAc synthesis serves as the platform for further O-antigen synthesis to which a Man was 
transferred by WreG. Compounds: I, Bp-PP-KdgNAc; II, Bp-PP-QuiNAc; III, Bp-PP-QuiNAc-Man.  
METHODS  
Bacterial strains and growth conditions  
Rhizobium etli CE3 was derived from R. etli wild-type strain CFN42 by a spontaneous mutation conferring 
resistance to streptomycin [ 38 ]. As in almost all past studies of the LPS of R. etli CFN42, strain CE3 was the wild-
type source of DNA and genotype for strain constructions. All R. etli strains were grown to stationary phase at 
30 °C in TY liquid medium [0.5 % tryptone (Difco Laboratories), 0.3 % yeast extract (Difco) and 10 mM CaCl 2]. All 
Escherichia coli strains were grown to stationary phase at 37 °C in Luria–Bertani (LB) liquid medium (1.0 % 
tryptone, 0.5 % yeast extract and 0.5 % NaCl). Agar medium contained 1.5 % Bacto Agar (Difco).  
 
DNA techniques  
Genomic DNA was isolated using GenElute Bacterial Genomic DNA Kit (Sigma-Aldrich) and plasmid DNA was 
isolated using QIAprep Spin Miniprep Kit (Qiagen). DNA extraction from agarose gels was performed using 
Gel/PCR DNA Fragments Extraction Kit (IBI Scientific). DNA amplification by PCR was performed using Expand 
High Fidelity PCR System (Roche Applied Science). Restriction enzymes and T4 DNA ligase were purchased from 
New England Biolabs (NEB).  
 
Cloning of R. etli wreU and wreG for overexpression  
The R. etli CE3 wreU gene was amplified from R. etli CE3 genomic DNA using primers 5′-CCGG 
CATATGGGCTTGAAACGGGCG-3′ (forward) and 5′-GGCC GGATCCCTAGTGCTTTATTCC-3′ (reverse). The PCR 
product was cloned into the pET15b vector (Novagen) using NdeI and BamHI sites, generating plasmid pLS5. It 
encodes the WreU protein with additional amino acids at the amino-terminus, MGSS HHHHHHSSGLVPRGSH (the 
6xHis tag is underlined). This WreU construct is referred to as His 6-WreU in this work.  
 
The R. etli CE3 wreG gene was amplified from R. etli CE3 genomic DNA using primers 5′- GC 
GCTAGCATGAGAGTCCTTCATTT-3′ (forward) and 5′-TT CTCGAGGCGGGAACCGGCCACGT-3′ (reverse). The PCR 
product was cloned into the pET21b vector (Novagen) using NheI and BamHI sites, generating plasmid pTL59. It 
encodes the WreG protein with amino-terminal additional amino acids MAS, and carboxy-terminal additional 
amino acids LE HHHHHH (the 6xHis tag is underlined). This WreG construct is referred to as WreG-His 6 in this 
work.  
 
Overexpression of His 6-WreU, WreG-His 6 and the polyprenyl kinase (DGK)  
Plasmid pLS5 (His 6-WreU) and pTL59 (WreG-His 6) were separately transformed into E. coli BL21(DE3) cells by 
electroporation. The polyprenol kinase used in these studies is expressed from cloned dgk DNA from 
Streptococcus mutans. Although homologous to E. coli dgk, the protein encoded by Streptococcus mutans dgk 
has higher [ 28 ], or much higher [ 39 ], kinase activity with undecaprenol as the substrate than with 
diacylglycerols. BL21 cells carrying a pET vector construct encoding this protein with a carboxy-terminal His 6-tag 
[ 28 ] was provided by Dr Barbara Imperiali, Massachusetts Institute of Technology, Cambridge, MA. Hereafter in 
this section, it will be referred to as DGK, to conform with the extant abbreviation in the literature.  
 
Expression of His 6-WreU, WreG-His 6 and DGK followed the same procedure: a flask of 1 l LB medium containing 
appropriate antibiotics (ampicillin 100 µg ml −1 for His 6-WreU and WreG-His 6, kanamycin 50 µg ml −1 for DGK) 
was inoculated with a 5 ml overnight start culture and shaken at 37 °C until an optical density between 0.6 and 
0.8 was reached. Then the flask was chilled for 1 h. Protein expression was induced by adding IPTG to the culture 
(1 mM for DGK, 0.01 mM for His 6-WreU and 0.1 mM for WreG-His 6), and the culture was shaken for a further 
20 h at 16 °C. Cells were harvested by centrifugation at 5000  g for 15 min at 4 °C, and the pellets was stored at 
−80 °C until needed.  
 
Complementation of R. etli CE3 mutants with the respective His-tagged constructs  
The DNA sequence-encoding His 6-WreU together with the RBS sequence was amplified from plasmid pLS5 with 
primers 5′-GCC GAATTCATACCCACGCCGAAACAAG-3′ (forward) and 5′-GCC GGTACCAGTTCCTCCTTTCAGCAAA-3′ 
(reverse). The PCR product was cloned into plasmid pFAJ1708 [ 40 ] with EcoRI and KpnI sites, generating 
plasmid pLS22.  
 
The DNA sequence-encoding WreG-His 6 together with the RBS sequence was amplified with primers 5′-GCC 
GAA TTCATACCCACGCCGAAACAAG-3′ (forward) and 5′-GCC GGTACCAGTTCCTCCTTTCAGCAAA-3′ (reverse). The 
PCR product was cloned into plasmid pFAJ1708 [ 40 ] with XbaI and KpnI sites, generating plasmid pTL63.  
 
Separately, pLS22 ( His 6-wreU ) was transferred into CE566 ( wreU::Km) and pTL63 ( wreG-His 6 ) was transferred 
into CE358 ( wreG::Tn 5) by triparental mating [ 41 ] with plasmid-mobilizer strain MT616 [ 42 ], as described 
previously [ 13 ]. Strains containing these constructs were selected on TY agar plates supplemented with 200 µg 
of streptomycin ml −1, 30 µg of nalidixic acid ml −1, 5 µg tetracycline ml −1, 30 µg of kanamycin ml −1. Single 
colonies were purified and analysed by SDS-PAGE.  
 
Preparation of membrane fractions  
Membrane fractions were prepared from E. coli cells expressing DGK, His 6-WreU and WreG-His 6 for use as 
crude enzyme or for purification of membrane-located proteins. Frozen cell pellets from 500 ml culture were 
thawed with lysis buffer (buffer A for DGK, 50 mM Tris, 1 mM ethylenediaminetetraacetic acid; buffer B for His 6-
WreU, 20 mM Tris, 300 mM NaCl, pH 8.5; buffer C for WreG-His 6, 20 mM sodium phosphate, 300 mM NaCl, 
5 mM imidazole, pH=7.0, with 14.3 mM 2-mercaptoethanol), and lysed by sonication. The lysate was centrifuged 
first at a low speed (6000  g , 20 min at 4 °C) to remove most of the cellular debris and then followed by a high 
speed spin (65 000  g , 120 min at 4 °C) to pellet the cell membrane fraction (stored at −80 °C if not used). The 
pellet of His 6-WreU and WreG-His 6 was homogenized in the respective lysis buffer and aliquoted into 100 µl 
fractions for storage at −80 °C.  
 
Purification of DGK from membrane fractions  
Frozen cell membrane was thawed and resuspended in 0.5 ml buffer D (20 mM sodium phosphate, 300 mM 
NaCl, 5 mM imidazole, pH 8.0) and incubated with 1 % CHAPS for 1 h at 4 °C to solubilize membrane proteins. 
Then the sample was incubated with 250 µl Ni 2+-profinity IMAC resin (Bio-Rad) for 30 min at 4 °C. The resin was 
placed in a 0.2 µm filter in a microcentrifuge tube for the subsequent wash and elution steps. The resin was 
washed twice with 375 µl of buffer D containing 1 % CHAPS, and twice with 375 µl of the same buffer with 
45 mM imidazole. The protein was eluted three times in 200 µl of the same buffer containing 300 mM imidazole. 
The combined elution fraction was dialysed and concentrated with an Amicon Ultra-0.5 (nominal molecular 
weight limit: 10 kDa) filter device. The concentrated protein was aliquoted into smaller fractions for storage at 
−80 °C.  
 
Purification of WreG-His 6 from membrane fractions  
One tube of 0.5 ml frozen cell membrane fraction was thawed and incubated with 1 % Triton X-100 for 2.5 h at 
4 °C. Then the sample was incubated with 200 µl Ni 2+-profinity IMAC resin (Bio-Rad) for 30 min at 4 °C. The resin 
was placed in a 0.2 µm filter in a microcentrifuge tube for the subsequent wash and elution steps. The resin was 
washed twice with 250 µl of buffer C containing 0.1 % Triton X-100, and twice with 250 µl of the same buffer 
with 20 mM imidazole. The protein was eluted twice in 250 µl of the same buffer containing 300 mM imidazole. 
Protein sample dialysis and concentration were performed exactly as described for DGK above.  
 
In vitro enzyme assays  
WreU GT assay – the lipid substrate Und-P was prepared according to [ 28 ] with modification. Briefly, 3 µl 
DMSO and 10 µl 10 % Triton X-100 were mixed with 13 nmol of dried undecaprenol (American Radiolabeled 
Chemicals). The tube was vortexed to ensure solubilization of the lipid. To the same tube, 5 µM [γ- 32P]-ATP 
(2000 mCi mmol −1) (PerkinElmer), 1 µl of purified DGK (~50 ng), 50 mM Tris buffer, pH 8.0, 40 mM MgCl 2 were 
added to a total volume of 100 µl. The DGK reaction was incubated at 30 °C for 1 h. To start the WreU enzyme 
assay, 1 µl (~2 µg) His 6-WreU membrane fraction was added to the DGK reaction. In the [ 32P]-WreU assay, 
nucleotide sugar substrates tested were: UDP-GlcNAc (Sigma), purified UDP-KdgNAc and UDP-QuiNAc. The 
concentration of each nucleotide sugar substrate was 0.05 mM.  
 
The WreU reactions were incubated at 30 °C for 1 h, then quenched into 500 µl of solvent I (chloroform-
methanol/3 : 2) and extracted with 400 µl PSUP (chloroform-methanol-1M MgCl 2-water/18 : 294 : 293 : 1) [ 43 ]. 
The organic layers were dried with lyophilization and re-dissolved in 20 µl solvent I. 1 µl of each sample was 
spotted on an aluminum-backed precoated Silica gel 60 plate (EMD Chemicals) and developed in TLC solvent A 
(2-propanol/ammonium hydroxide/water, 6 : 3 : 1). Dried TLC plates were exposed to films or photostimulable 
phosphor (PSP) plates and viewed by autoradiogram.  
 
WreU-WreQ-coupled assay – the WreU reactions with UDP-KdgNAc as the substrate were incubated for 1 h at 
30 °C. To the WreU reactions, 0.1 mM NADH and 1 µl (~10 µg) WreQ enzyme were added. The reactions were 
allowed to proceed for 1 h at 30 °C after WreQ addition. Then they were quenched and prepared for analysis as 
described above for WreU enzyme assay.  
 
WreU-WreQ-WreG-coupled reaction – in reactions that aimed to test the GT activity of WreG, 10 µl crude 
(~10 µg) or purified WreG enzyme (~40 µg) and 0.1 mM GDP-Man were added to [ 32P]-WreU reactions together 
with (or without) 10 µg WreQ and 0.1 mM NADH. Reactions were allowed for 1 h after adding WreG and then 
quenched and prepared for TLC analysis. For analysis of the reaction products, two TLC solvents were used: 
solvent A and solvent B (choloform/methanol/water, 65 : 25 : 4).  
 
Rate comparison of WreQ-catalysed reaction with different substrates  
To estimate the rate of the WreQ reaction with nucleotide sugar substrate, 10 µg His 6-WreQ protein and 1 mM 
NADH were added to the WbpM reaction which was incubated for 30 min to generate product UDP-KdgNAc [ 19 
] and the WreQ reactions were quenched at 1, 5 and 30 min. Reducing the WreQ enzyme concentration by a 
factor of 10 was attempted which led to a very slow reaction, thus only one concentration of WreQ was used for 
this reaction.  
 
To estimate the rate of the WreQ reaction with the lipidated substrate, firstly [ 32P] WreU transferase reactions 
with the UDP-KdgNAc substrate for 1 h. Then 0.1 mM NADH and 1 µl serially diluted WreQ enzyme (10 −6, 10 −5, 
10 −4, 10 −3, 10 −2, 10 −1 and undiluted) was added and the WreQ reactions were allowed for only 1 min. In one 
reaction, solvent I was added before the addition of the WreQ enzyme as a 0 min control, to show that the 
method of quenching the reactions was effective. The organic phases of these reactions were analysed by TLC. 
Radioactive ( 32P) spots were quantified by phosphorimager and used for estimating reaction kinetics.  
FUNDING INFORMATION  
This work was supported by National Institutes of Health Grant 1 R15 GM087699-01A1. 
ACKNOWLEDGEMENTS  
We thank Dr Barbara Imperiali for the gift of an expression vector construct encoding the Streptococcus mutans 
undecaprenol kinase with a carboxy-terminal His 6-tag and Dr J. S. Lam for providing the WbpM-His-S262 
expression vector.  
CONFLICTS OF INTEREST  
The authors declare that there are no conflicts of interest. 
REFERENCES  
1. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002; 71: 635– 700  
2. Frank MM, Joiner K, Hammer C. The function of antibody and complement in the lysis of bacteria. Rev 
Infect Dis 1987; 9: S537– S545  
3. Bowden MG, Kaplan HB. The Myxococcus xanthus lipopolysaccharide O-antigen is required for social 
motility and multicellular development. Mol Microbiol 1998; 30: 275– 284  
4. Toguchi A, Siano M, Burkart M, Harshey RM. Genetics of swarming motility in Salmonella enterica 
serovar typhimurium: critical role for lipopolysaccharide. J Bacteriol 2000; 182: 6308– 6321  
5. Kierek K, Watnick PI. The Vibrio cholerae O139 O-antigen polysaccharide is essential for Ca2+-dependent 
biofilm development in sea water. Proc Natl Acad Sci USA 2003; 100: 14357– 14362  
6. Hölzer SU, Schlumberger MC, Jäckel D, Hensel M. Effect of the O-antigen length of lipopolysaccharide on 
the functions of type III secretion systems in Salmonella enterica. Infect Immun 2009; 77: 5458– 5470  
7. Morgenstein RM, Clemmer KM, Rather PN. Loss of the waaL O-antigen ligase prevents surface activation 
of the flagellar gene cascade in Proteus mirabilis. J Bacteriol 2010; 192: 3213– 3221  
8. Post DM, Yu L, Krasity BC, Choudhury B, Mandel MJ et al. O-antigen and core carbohydrate of Vibrio 
fischeri lipopolysaccharide: composition and analysis of their role in Euprymna scolopes light organ 
colonization. J Biol Chem 2012; 287: 8515– 8530  
9. Noel KD, Vandenbosch KA, Kulpaca B. Mutations in Rhizobium phaseoli that lead to arrested 
development of infection threads. J Bacteriol 1986; 168: 1392– 1401  
10. Carlson RW, Kalembasa S, Turowski D, Pachori P, Noel KD. Characterization of the lipopolysaccharide 
from a Rhizobium phaseoli mutant that is defective in infection thread development. J Bacteriol 1987; 
169: 4923– 4928  
11. Cava JR, Elias PM, Turowski DA, Noel KD. Rhizobium leguminosarum CFN42 genetic regions encoding 
lipopolysaccharide structures essential for complete nodule development on bean plants. J Bacteriol 
1989; 171: 8– 15 Forsberg LS, Bhat UR, Carlson RW. Structural characterization of the O-antigenic 
polysaccharide of the lipopolysaccharide from Rhizobium etli strain CE3. A unique O-acetylated glycan of 
discrete size, containing 3-O-methyl-6-deoxy-l-talose and 2,3,4-tri-O-methyl-l-fucose. J Biol Chem 2000; 
275: 18851– 18863   
12. Ojeda KJ, Simonds L, Noel KD. Roles of predicted glycosyltransferases in the biosynthesis of the 
Rhizobium etli CE3 O antigen. J Bacteriol 2013; 195: 1949– 1958 Valvano MA. Export of O-specific 
lipopolysaccharide. Front Biosci 2003; 8: s452– s471 Price NP, Momany FA. Modeling bacterial UDP-
HexNAc: polyprenol-P HexNAc-1-P transferases. Glycobiology 2005; 15: 29R– 42R  
13. Al-Dabbagh B, Mengin-Lecreulx D, Bouhss A. Purification and characterization of the bacterial UDP-
GlcNAc:undecaprenyl-phosphate GlcNAc-1-phosphate transferase WecA. J Bacteriol 2008; 190: 7141– 
7146  
14. Merino S, Jimenez N, Molero R, Bouamama L, Regué M et al. A UDP-HexNAc:polyprenol-P GalNAc-1-P 
transferase (WecP) representing a new subgroup of the enzyme family. J Bacteriol 2011; 193: 1943– 
1952  
15. Patel KB, Ciepichal E, Swiezewska E, Valvano MA. The C-terminal domain of the Salmonella enterica 
WbaP (UDP-galactose:Und-P galactose-1-phosphate transferase) is sufficient for catalytic activity and 
specificity for undecaprenyl monophosphate. Glycobiology 2012; 22: 116– 122  
16. Li T, Simonds L, Kovrigin EL, Noel KD. In vitro biosynthesis and chemical identification of UDP-N-acetyl-d-
quinovosamine (UDP-d-QuiNAc). J Biol Chem 2014; 289: 18110– 18120  
17. Hwang S, Aronov A, Bar-Peled M. The Biosynthesis of UDP-d-QuiNAc in Bacillus cereus ATCC 14579. PLoS 
One 2015; 10: e0133790  
18. Creuzenet C, Schur MJ, Li J, Wakarchuk WW, Lam JS. FlaA1, a new bifunctional UDP-GlcNAc C6 
Dehydratase/ C4 reductase from Helicobacter pylori. J Biol Chem 2000; 275: 34873– 34880  
19. Creuzenet C, Lam JS. Topological and functional characterization of WbpM, an inner membrane UDP-
GlcNAc C6 dehydratase essential for lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Mol 
Microbiol 2001; 41: 1295– 1310  
20. Olivier NB, Chen MM, Behr JR, Imperiali B. In vitro biosynthesis of UDP-N,N'-diacetylbacillosamine by 
enzymes of the Campylobacter jejuni general protein glycosylation system. Biochemistry 2006; 45: 
13659– 13669 Schoenhofen IC, Mcnally DJ, Vinogradov E, Whitfield D, Young NM et al. Functional 
characterization of dehydratase/aminotransferase pairs from Helicobacter and Campylobacter: enzymes 
distinguishing the pseudaminic acid and bacillosamine biosynthetic pathways. J Biol Chem 2006; 281: 
723– 732  
21. Pinta E, Duda KA, Hanuszkiewicz A, Kaczyński Z, Lindner B et al. Identification and role of a 6-deoxy-4-
keto-hexosamine in the lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3. Chemistry 
2009; 15: 9747– 9754  
22. Noel KD, Forsberg LS, Carlson RW. Varying the abundance of O antigen in Rhizobium etli and its effect on 
symbiosis with Phaseolus vulgaris. J Bacteriol 2000; 182: 5317– 5324  
23. Forsberg LS, Noel KD, Box J, Carlson RW. Genetic locus and structural characterization of the biochemical 
defect in the O-antigenic polysaccharide of the symbiotically deficient Rhizobium etli mutant, CE166. 
Replacement of N-acetylquinovosamine with its hexosyl-4-ulose precursor. J Biol Chem 2003; 278: 
51347– 51359  
24. Hartley MD, Larkin A, Imperiali B. Chemoenzymatic synthesis of polyprenyl phosphates. Bioorg Med 
Chem 2008; 16: 5149– 5156  
25. Osborn MJ, Cynkin MA, Gilbert JM, Müller L, Singh M et al. Synthesis of bacterial O-antigens. In Methods 
in enzymology Academic Press; 1972; pp. 583– 601  
26. Schäffer C, Wugeditsch T, Messner P, Whitfield C. Functional expression of enterobacterial O-
polysaccharide biosynthesis enzymes in Bacillus subtilis. Appl Environ Microbiol 2002; 68: 4722– 4730  
27. Kanjilal-Kolar S, Basu SS, Kanipes MI, Guan Z, Garrett TA et al. Expression cloning of three Rhizobium 
leguminosarum lipopolysaccharide core galacturonosyltransferases. J Biol Chem 2006; 281: 12865– 
12878  
28. Glover KJ, Weerapana E, Chen MM, Imperiali B. Direct biochemical evidence for the utilization of UDP-
bacillosamine by PglC, an essential glycosyl-1-phosphate transferase in the Campylobacter jejuni N-
linked glycosylation pathway. Biochemistry 2006; 45: 5343– 5350  
29. Lukose V, Luo L, Kozakov D, Vajda S, Allen KN et al. Conservation and covariance in small bacterial 
phosphoglycosyltransferases identify the functional catalytic core. Biochemistry 2015; 54: 7326– 7334  
30. Rush JS, Alaimo C, Robbiani R, Wacker M, Waechter CJ. A novel epimerase that converts GlcNAc-P-P-
undecaprenol to GalNAc-P-P-undecaprenol in Escherichia coli O157. J Biol Chem 2010; 285: 1671– 1680  
31. Cunneen MM, Liu B, Wang L, Reeves PR. Biosynthesis of UDP-GlcNAc, UndPP-GlcNAc and UDP-GlcNAcA 
involves three easily distinguished 4-epimerase enzymes, Gne, Gnu and GnaB. PLoS One 2013; 8: e67646  
32. Vinogradov E, Frirdich E, Maclean LL, Perry MB, Petersen BO et al. Structures of lipopolysaccharides 
from Klebsiella pneumoniae. Eluicidation of the structure of the linkage region between core and 
polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains. J 
Biol Chem 2002; 277: 25070– 25081  
33. Casillo A, Parrilli E, Sannino F, Mitchell DE, Gibson MI et al. Structure-activity relationship of the 
exopolysaccharide from a psychrophilic bacterium: a strategy for cryoprotection. Carbohydr Polym 
2017; 156: 364– 371  
34. Noel KD, Sanchez A, Fernandez L, Leemans J, Cevallos MA. Rhizobium phaseoli symbiotic mutants with 
transposon Tn5 insertions. J Bacteriol 1984; 158: 148– 155  
35. Lis M, Kuramitsu HK. The stress-responsive dgk gene from Streptococcus mutans encodes a putative 
undecaprenol kinase activity. Infect Immun 2003; 71: 1938– 1943  
36. Dombrecht B, Vanderleyden J, Michiels J. Stable RK2-derived cloning vectors for the analysis of gene 
expression and gene function in gram-negative bacteria. Mol Plant Microbe Interact 2001; 14: 426– 430  
37. Glazebrook J, Walker GC. Genetic techniques in Rhizobium meliloti. Methods Enzymol 1991; 204: 398– 
418  
38. Finan TM, Kunkel B, de Vos GF, Signer ER. Second symbiotic megaplasmid in Rhizobium meliloti carrying 
exopolysaccharide and thiamine synthesis genes. J Bacteriol 1986; 167: 66– 72  
39. Patel KB, Valvano MA. In vitro UDP-sugar:undecaprenyl-phosphate sugar-1-phosphate transferase assay 
and product detection by thin layer chromatography. Methods Mol Biol 2013; 1022: 173– 183  
40. El Ghachi M, Bouhss A, Blanot D, Mengin-Lecreulx D. The bacA gene of Escherichia coli encodes an 
undecaprenyl pyrophosphate phosphatase activity. J Biol Chem 2004; 279: 30106– 30113  
SUPPLEMENTARY MATERIALS 
Table S1. Bacterial strains containing homologs of R. etli CE3 WreQ, WreU and WreV.  
WreQ (YP_470339.1), WreU (YP_471772.1), WreV (YP_471773.1) were used individually as the query sequences 
in BLAST searches against the non-redundant protein sequence (nr) database using the blastp algorithm. In the 
first WreQ and WreU BLAST searches, Rhizobiaceae were excluded (to eliminate the very high number of 
Rhizobium and closely affiliated rhizobial strains) and the max target sequences were 1000 and 5000 
respectively. All saved strains from that search had WreU homologs with E-values of less than 1e-30; the WreQ 
homologs of these strains had E-values less than 1e-89. In the WreV BLAST search, initially the strategy was the 
same as with WreQ, and all the resulting sequences had an E-value of 0.0. However, the majority of sequences 
belonged to Pseudomonadaceae. Thus, a separate blast was performed to exclude Pseudomonadaceae as well, 
and with 5000 max target sequences, resulting in E-values less than 2e-127. Finally a search of only “Alpha-
Proteobacteriaceae” was conducted and species, rather than strains, with homologs to all three genes were 
saved.  In this final table, strains containing the three gene homologs are listed, with the accession numbers of 
the protein homologs.  The E-values are less than 1e-50, 1e-30, and 4e-70 for matches with WreQ, WreU, and 
WreV, respectively.  Where a strain number is not provided, it can be found through the gene accession 
numbers.  The Phylo column indicates the phylogenetic affiliation of the strain within the domain Bacteria:  FCB 
refers to the super-phylum FCB within the Bacteria; Alpha, Beta, Gamma, Delta, and Zeta refer to the sub-phyla 
within the Proteobacteria. 
 
 Strain  WreQ accession  WreU accession  WreV accession  Phylo  
Chlorobium phaeobacteroides  WP_015961134.1  WP_041467797.1  WP_015961150.1  FCB  
Pelodictyon phaeoclathratiforme  WP_012507375.1  WP_012507376.1  WP_012507339.1  FCB  
Agrobacterium rhizogenes  WP_034519680.1  WP_034519733.1  WP_034514206.1  Alpha  
Aureimonas altamirensis  WP_060606375.1  WP_060601527.1  WP_039195620.1  Alpha  
Aureimonas frigidaquae  WP_062227553.1  WP_062227554.1  WP_062227987.1  Alpha  
Azospirillum brasilense  WP_035680550.1  WP_014198799.1  WP_014240519.1  Alpha  
Bradyrhizobium  WP_027564699.1  WP_028141810.1  WP_027564879.1  Alpha  
Bradyrhizobium canariense  WP_085348811.1  WP_085384688.1  WP_085394538.1  Alpha  
Bradyrhizobium erythrophlei  WP_079604300.1  WP_074274213.1  WP_092115479.1  Alpha  
Candidatus Pelagibacter ubique  WP_029454191.1  WP_075521062.1  WP_029454193.1  Alpha  
Mesorhizobium alhagi  WP_085984070.1  WP_008835798.1  WP_008835795.1  Alpha  
Methylobacterium extorquens  WP_076643959.1  WP_015822390.1  WP_076643956.1  Alpha  
Pseudooceanicola nitratireducens  WP_093454891.1  WP_093454896.1  WP_093447298.1  Alpha  
Rhizobiales bacterium 63-7  OJU66100.1  OJU71699.1  OJU71698.1  Alpha  
Rhizobium acidisoli  WP_054182687.1  WP_054185004.1  WP_054185003.1  Alpha  
Rhizobium aegyptiacum  WP_064694690.1  WP_064696812.1  WP_064696703.1  Alpha  
Rhizobium aethiopicum  WP_092748744.1  SCB62257.1  SCB58533.1  Alpha  
Rhizobium alamii  WP_037099615.1  WP_051942476.1  WP_051942478.1  Alpha  
Rhizobium bangladeshense  WP_064705588.1  WP_064712006.1  WP_064710004.1  Alpha  
Rhizobium etli  WP_011426089.1  WP_011427467.1  WP_011427468.1  Alpha  
Rhizobium favelukesii  WP_024317389.1  WP_024314414.1  WP_024317388.1  Alpha  
Rhizobium freirei  WP_004127129.1  WP_037155461.1  WP_004126244.1  Alpha  
Rhizobium gallicum  WP_018446548.1  WP_026230627.1  WP_083636055.1  Alpha  
Rhizobium hainanense  WP_075853437.1  SCB21882.1  WP_075856697.1  Alpha  
Rhizobium laguerreae  WP_077978790.1  WP_077979743.1  WP_077979742.1  Alpha  
Rhizobium leguminosarum  WP_037140272.1  WP_027687178.1  WP_027687179.1  Alpha  
Rhizobium marinum  WP_029621142.1  WP_029618564.1  WP_081852123.1  Alpha  
Rhizobium mesoamericanum  WP_040678303.1  WP_007537568.1  WP_028745825.1  Alpha  
Rhizobium miluonense  WP_092851701.1  SCB34436.1  WP_092843462.1  Alpha  
Rhizobium multihospitium  WP_092720446.1  WP_092720448.1  WP_092714704.1  Alpha  
Rhizobium phaseoli  WP_064818631.1  WP_085744233.1  WP_064837511.1  Alpha  
Rhizobium tibeticum  WP_072375736.1  WP_072373828.1  WP_072375735.1  Alpha  
Rhizobium tropici  WP_015341683.1  WP_015341684.1  WP_015338445.1  Alpha  
Rhizobium/Agrobacterium group  WP_007694703.1  WP_007694702.1  WP_047524929.1  Alpha  
Rhodopseudomonas palustris  WP_041798076.1  WP_080506310.1  WP_080674905.1  Alpha  
Sphingopyxis macrogoltabida  WP_054589353.1  WP_054590413.1  WP_082396031.1  Alpha  
Acidovorax soli  SEA14343.1  SEA14367.1  SEA14422.1  Beta  
Acidovorax wautersii  WP_092939072.1  WP_092939071.1  WP_092939238.1  Beta  
Burkholderia sp. 9120  WP_035552665.1  WP_035552664.1  WP_035552662.1  Beta  
Burkholderiales bacterium 
RIFCSPLOWO2_12_FULL_61_40  
OGB28531.1  OGB28530.1  OGB28529.1  Beta  
Candidatus Accumulibacter sp. 66-26  OJW49362.1  OJW49363.1  OJW49596.1  Beta  
Candidatus Methylopumilus turicensis  WP_082048396.1  WP_045751174.1  WP_045751173.1  Beta  
Comamonadaceae bacterium 
CG1_02_60_18  
OIN91272.1  OIN91271.1  OIN91269.1  Beta  
Comamonadaceae bacterium 
CG2_30_57_122  
OIP13220.1  OIP13227.1  OIP13228.1  Beta  
Cupriavidus sp. WS  WP_081651598.1  WP_029044350.1  WP_043367598.1  Beta  
Deefgea rivuli  WP_027469006.1  WP_027469005.1  WP_027469004.1  Beta  
Herbaspirillum aquaticum  WP_088756155.1  WP_088753704.1  WP_088756171.1  Beta  
Herbaspirillum frisingense  WP_039875505.1  WP_079216977.1  WP_079216979.1  Beta  
Herbaspirillum rubrisubalbicans  WP_058894123.1  WP_058894118.1  WP_082686138.1  Beta  
Herbaspirillum seropedicae  WP_069375417.1  WP_069375029.1  WP_069375030.1  Beta  
Herbaspirillum sp. B39  WP_034337931.1  WP_034330935.1  WP_034330937.1  Beta  
Herbaspirillum sp. HZ10  WP_088752243.1  WP_088752242.1  WP_088752241.1  Beta  
Herbaspirillum sp. RV1423  WP_034299669.1  WP_081768878.1  WP_081768877.1  Beta  
Herbaspirillum sp. WT00C  WP_075259658.1  WP_075255625.1  WP_075255626.1  Beta  
Herbaspirillum sp. YR522  WP_008117337.1  WP_008113559.1  WP_008117346.1  Beta  
Herminiimonas arsenicoxydans  WP_011870663.1  WP_011870664.1  WP_011870665.1  Beta  
Herminiimonas arsenitoxidans  WP_076593873.1  WP_076590916.1  WP_076590917.1  Beta  
Hydrogenophaga palleronii  WP_066269231.1  WP_066269232.1  WP_066269233.1  Beta  
Hydrogenophaga sp. IBVHS1  WP_086126805.1  WP_086126802.1  WP_086126799.1  Beta  
Hydrogenophaga sp. PML113  WP_083293270.1  WP_070400211.1  WP_070400209.1  Beta  
Hydrogenophaga sp. RAC07  WP_083240110.1  WP_069049138.1  WP_069048529.1  Beta  
Hydrogenophaga sp. Root209  WP_082585539.1  WP_056267373.1  WP_056267049.1  Beta  
Hydrogenophaga sp. SCN 70-13  ODT34034.1  ODT34033.1  ODT34031.1  Beta  
Janthinobacterium  WP_086138461.1  WP_086138462.1  WP_086138463.1  Beta  
Janthinobacterium agaricidamnosum  WP_038489190.1  WP_038498699.1  WP_038489192.1  Beta  
Janthinobacterium lividum  WP_070254296.1  WP_070254295.1  WP_070254294.1  Beta  
Janthinobacterium sp. Ant5-2-1  WP_058049808.1  WP_058049809.1  WP_058049810.1  Beta  
Janthinobacterium sp. GW458P  WP_086143996.1  WP_086143912.1  WP_086143913.1  Beta  
Janthinobacterium sp. KBS0711  WP_046686130.1  WP_046686131.1  WP_046686132.1  Beta  
Janthinobacterium sp. Marseille  WP_012080109.1  ABR88537.1  WP_012080107.1  Beta  
Janthinobacterium sp. S3-2  WP_065307061.1  WP_065307060.1  WP_065307077.1  Beta  
Janthinobacterium sp. TND4EL3  WP_076565808.1  WP_076565810.1  WP_076565792.1  Beta  
Laribacter hongkongensis  WP_027824056.1  WP_027824055.1  WP_027824054.1  Beta  
Laribacter hongkongensis  WP_088861422.1  WP_088861421.1  WP_088861420.1  Beta  
Limnohabitans planktonicus  WP_053170360.1  WP_053170358.1  WP_053171553.1  Beta  
Methylotenera mobilis  WP_041928542.1  WP_015831982.1  WP_015831983.1  Beta  
Methylotenera sp. G11  WP_081987064.1  WP_047549180.1  WP_047549183.1  Beta  
Methylotenera sp. L2L1  WP_036303317.1  WP_036303315.1  WP_036303313.1  Beta  
Methylotenera sp. 
RIFCSPLOWO2_02_FULL_45_14  
OGV78172.1  OGV78179.1  OGV77391.1  Beta  
Methylotenera versatilis  WP_013147951.1  WP_041359898.1  WP_013147953.1  Beta  
Methylovorus sp. MP688  WP_013440922.1  WP_013440921.1  WP_013442499.1  Beta  
Noviherbaspirillum autotrophicum  WP_040038466.1  WP_040038467.1  WP_040038468.1  Beta  
Noviherbaspirillum massiliense  WP_019141885.1  WP_026075971.1  WP_019141883.1  Beta  
Pandoraea pnomenusa  WP_023598438.1  WP_023598439.1  WP_052167323.1  Beta  
Pandoraea vervacti  WP_044458602.1  WP_044457406.1  WP_044458601.1  Beta  
Paraburkholderia phenazinium  WP_090690488.1  WP_090690491.1  WP_090690498.1  Beta  
Paraburkholderia sartisoli  WP_090532012.1  WP_090532010.1  WP_090532007.1  Beta  
Paraburkholderia terrae  WP_086909626.1  WP_086909596.1  WP_086909597.1  Beta  
Polaromonas glacialis  WP_029526176.1  WP_029526175.1  WP_029526173.1  Beta  
Polaromonas jejuensis  WP_068831299.1  WP_068831300.1  WP_084389288.1  Beta  
Polaromonas naphthalenivorans  WP_011802850.1  WP_011802849.1  WP_011802848.1  Beta  
Polaromonas sp. A23  WP_077592725.1  WP_077592843.1  WP_077592727.1  Beta  
Polaromonas sp. C04  WP_077563849.1  WP_077563851.1  WP_077563857.1  Beta  
Polaromonas sp. CF318  WP_007862413.1  EJL78603.1  EJL78604.1  Beta  
Polaromonas sp. CG9_12  WP_036808892.1  WP_036813202.1  WP_036808899.1  Beta  
Polaromonas sp. EUR3 1.2.1  WP_026781163.1  WP_026781159.1  WP_026781158.1  Beta  
Polaromonas sp. JS666  WP_011484870.1  WP_011484869.1  WP_011484867.1  Beta  
Polaromonas sp. OV174  WP_091998443.1  WP_091998447.1  WP_091998450.1  Beta  
Pseudorhodoferax sp. Leaf265  WP_056672590.1  WP_056672588.1  WP_056672598.1  Beta  
Rhodoferax antarcticus  WP_075585179.1  WP_075585216.1  WP_075585168.1  Beta  
Rhodoferax fermentans  WP_078364450.1  WP_078366834.1  WP_078364448.1  Beta  
Rhodoferax ferrireducens  OQW88136.1  OQW86158.1  OQW88139.1  Beta  
Rhodoferax sp. DCY110  WP_076197995.1  WP_076197993.1  WP_076198007.1  Beta  
Sulfuriferula sp. AH1  WP_087447710.1  WP_087447709.1  WP_087447732.1  Beta  
Thauera humireducens  WP_048706753.1  WP_048706755.1  AMO37809.1  Beta  
Thauera terpenica  WP_040831089.1  WP_021250246.1  WP_021250247.1  Beta  
Variovorax paradoxus  WP_057595238.1  WP_013543050.1  WP_062361990.1  Beta  
Variovorax sp. CF313  WP_042673666.1  WP_007835336.1  WP_007835345.1  Beta  
Variovorax sp. JS1663  WP_086924577.1  WP_086924597.1  WP_086924576.1  Beta  
delta proteobacterium MLMS-1  WP_007292162.1  WP_007294049.1  WP_007294051.1  Delta  
Geoalkalibacter ferrihydriticus  WP_074669617.1  WP_040101187.1  WP_052446538.1  Delta  
Geobacter bemidjiensis  WP_012530059.1  WP_012530060.1  WP_012530067.1  Delta  
Geobacter sp. DSM 9736  WP_088533764.1  WP_088536670.1  WP_088533767.1  Delta  
Geobacter sp. M21  WP_015837859.1  WP_015837858.1  WP_015837853.1  Delta  
Geobacteraceae bacterium 
GWB2_52_12  
OGT95934.1  OGT95928.1  OGT95936.1  Delta  
Alishewanella aestuarii  WP_008608033.1  WP_008608034.1  WP_008608039.1  Gamma  
Alishewanella sp. HH-ZS  WP_065956080.1  WP_065956079.1  WP_065956072.1  Gamma  
Arsukibacterium ikkense  WP_046556227.1  WP_046556226.1  WP_052748930.1  Gamma  
Arsukibacterium sp. MJ3  WP_046555083.1  WP_046555081.1  WP_052750195.1  Gamma  
Catenovulum maritimum  WP_048693212.1  WP_048693214.1  WP_048693216.1  Gamma  
Chania multitudinisentens  WP_024911805.1  WP_024911804.1  WP_024911803.1  Gamma  
Colwellia psychrerythraea  WP_033083676.1  WP_033093120.1  WP_033093119.1  Gamma  
Colwellia sp. TT2012  WP_057830224.1  WP_057832342.1  WP_057830226.1  Gamma  
Crenothrix polyspora  WP_087147254.1  WP_087147253.1  WP_087147252.1  Gamma  
Cycloclasticus sp. DSM 27168  WP_073023169.1  WP_073023168.1  WP_073023165.1  Gamma  
Endozoicomonas atrinae  WP_066015304.1  WP_066015305.1  WP_066015306.1  Gamma  
Halomonas pantelleriensis  WP_089656468.1  WP_089656469.1  WP_089656471.1  Gamma  
Halomonas salina  WP_040186301.1  WP_081945756.1  WP_040186321.1  Gamma  
Lonsdalea quercina  WP_094107939.1  WP_094107961.1  WP_094107940.1  Gamma  
Marinobacter hydrocarbonoclasticus  WP_011786059.1  WP_011786058.1  WP_011786057.1  Gamma  
Marinobacter lipolyticus  WP_018405035.1  WP_018405034.1  WP_018405033.1  Gamma  
Marinobacter salinus  WP_070965578.1  WP_070973522.1  WP_070965581.1  Gamma  
Marinobacterium lutimaris  SEG57113.1  SEG57098.1  SEG57078.1  Gamma  
Methyloglobulus morosus  WP_023495340.1  WP_023495341.1  WP_023495342.1  Gamma  
Methylophaga sp. 41_12_T18  OUR72752.1  OUR72751.1  OUR72772.1  Gamma  
Nitrincola nitratireducens  WP_036513279.1  EXJ09743.1  EXJ09744.1  Gamma  
Oceanimonas sp. GK1  WP_041543213.1  WP_014293024.1  WP_014293023.1  Gamma  
Oleiphilus  WP_068474530.1  WP_068553922.1  WP_068474520.1  Gamma  
Photobacterium ganghwense  WP_047883801.1  WP_047883800.1  WP_047883802.1  Gamma  
Photobacterium iliopiscarium  WP_045038329.1  WP_045038330.1  WP_045038331.1  Gamma  
Photobacterium kishitanii  WP_065173147.1  WP_065173146.1  WP_065173145.1  Gamma  
Photobacterium leiognathi  WP_023931563.1  WP_023931565.1  WP_045063689.1  Gamma  
Photobacterium marinum  WP_007466443.1  WP_007466442.1  WP_036800127.1  Gamma  
Photobacterium sp. SKA34  WP_006646475.1  WP_006646476.1  WP_039860628.1  Gamma  
Photorhabdus asymbiotica  WP_065821825.1  WP_065821916.1  WP_065821915.1  Gamma  
Photorhabdus asymbiotica  WP_036770100.1  WP_036770139.1  WP_036770093.1  Gamma  
Pseudoalteromonas  WP_024589810.1  WP_024589809.1  WP_024589808.1  Gamma  
Pseudoalteromonas lipolytica  WP_074989256.1  WP_074989257.1  WP_074989258.1  Gamma  
Pseudoalteromonas luteoviolacea  WP_063378454.1  WP_063378455.1  WP_063378456.1  Gamma  
Pseudoalteromonas luteoviolacea  WP_039608254.1  WP_039608255.1  WP_039608256.1  Gamma  
Pseudoalteromonas rubra  WP_049864426.1  WP_046007017.1  WP_049864427.1  Gamma  
Pseudoalteromonas sp. BMB  WP_069020842.1  WP_069020844.1  WP_069020848.1  Gamma  
Pseudoalteromonas sp. BSi20429  WP_007584995.1  WP_007584994.1  WP_033026984.1  Gamma  
Pseudomonas aeruginosa  WP_023130787.1  WP_023120375.1  WP_023130786.1  Gamma  
Pseudomonas alcaliphila  WP_075747014.1  WP_064494598.1  WP_064494599.1  Gamma  
Pseudomonas antarctica  WP_064451500.1  WP_064451502.1  WP_083359481.1  Gamma  
Pseudomonas brassicacearum  ALQ02335.1  WP_025212585.1  WP_081352378.1  Gamma  
Pseudomonas chengduensis  WP_090336757.1  WP_090336759.1  WP_090336760.1  Gamma  
Pseudomonas chlororaphis  WP_053269669.1  WP_053280338.1  WP_053280337.1  Gamma  
Pseudomonas composti  WP_074940188.1  WP_074940192.1  WP_074940422.1  Gamma  
Pseudomonas fluorescens  WP_034155277.1  WP_034126702.1  WP_034126705.1  Gamma  
Pseudomonas fluorescens  WP_003183858.1  WP_003189797.1  WP_003189805.1  Gamma  
Pseudomonas frederiksbergensis  WP_076031558.1  WP_071554248.1  WP_071554254.1  Gamma  
Pseudomonas oleovorans  WP_037054107.1  WP_037054105.1  WP_037054102.1  Gamma  
Pseudomonas psychrotolerans  WP_058761729.1  WP_058760362.1  WP_058761296.1  Gamma  
Pseudomonas putida  WP_069942133.1  WP_069942135.1  WP_069942131.1  Gamma  
Pseudomonas sp. 1-7  KFJ93089.1  KFJ93088.1  KFJ93087.1  Gamma  
Pseudomonas sp. C5pp  WP_039615100.1  WP_039615098.1  WP_039615101.1  Gamma  
Pseudomonas sp. GM48  WP_007988308.1  WP_007985416.1  WP_007985421.1  Gamma  
Pseudomonas sp. M30-35  WP_087516444.1  WP_087516445.1  WP_087516446.1  Gamma  
Pseudomonas sp. MT-1  WP_045428458.1  WP_045428457.1  WP_045428456.1  Gamma  
Pseudomonas sp. NFACC19-2  WP_072424717.1  WP_072424718.1  WP_072424719.1  Gamma  
Pseudomonas stutzeri  WP_063540504.1  WP_063540515.1  WP_063540503.1  Gamma  
Pseudomonas synxantha  WP_057022239.1  WP_057022149.1  WP_057022240.1  Gamma  
Pseudomonas toyotomiensis  WP_074914515.1  WP_059391714.1  WP_059391715.1  Gamma  
Pseudomonas veronii  WP_046483495.1  WP_046384274.1  WP_046384261.1  Gamma  
Psychromonas aquimarina  WP_028862360.1  WP_028862361.1  WP_028862362.1  Gamma  
Psychromonas ossibalaenae  WP_019615916.1  WP_019615917.1  WP_019615919.1  Gamma  
Rheinheimera perlucida  WP_019674728.1  WP_019674726.1  WP_019674701.1  Gamma  
Sedimenticola thiotaurini  WP_046859767.1  WP_046859766.1  WP_046859765.1  Gamma  
Shewanella algae  WP_071237806.1  WP_071477444.1  WP_071237804.1  Gamma  
Thioalkalivibrio sp. AKL10  WP_026340938.1  WP_081624528.1  WP_026340942.1  Gamma  
Thioalkalivibrio sp. AKL12  WP_018951797.1  WP_018951790.1  WP_026289538.1  Gamma  
Thioalkalivibrio sp. AKL6  WP_018145916.1  WP_026182128.1  WP_018145952.1  Gamma  
Thioalkalivibrio sp. AKL7  WP_081624430.1  WP_019611620.1  WP_019612086.1  Gamma  
Thioalkalivibrio sp. AKL8  WP_026304840.1  WP_081623074.1  WP_026304844.1  Gamma  
Thioalkalivibrio sp. ALJ16  WP_018873978.1  WP_026280011.1  WP_018872892.1  Gamma  
Thioalkalivibrio sp. ALM2T  WP_026333161.1  WP_026333164.1  WP_026333157.1  Gamma  
Thioalkalivibrio sp. ALMg13-2  WP_019568703.1  WP_081620896.1  WP_026331226.1  Gamma  
Thioalkalivibrio sp. ALMg2  WP_019563934.1  WP_081621424.1  WP_026330565.1  Gamma  
Thioalkalivibrio sp. ALMg9  WP_018169554.1  WP_081620143.1  WP_026305952.1  Gamma  
Thioalkalivibrio sp. K90mix  WP_012982927.1  WP_012982924.1  WP_012982951.1  Gamma  
Thioalkalivibrio versutus  WP_047250985.1  WP_047250991.1  WP_047251909.1  Gamma  
Thiothrix lacustris  OQX06987.1  OQX08772.1  OQX02620.1  Gamma  
Vibrio alginolyticus  WP_086050204.1  WP_065646566.1  WP_065646570.1  Gamma  
Vibrio anguillarum  AQP34955.1  WP_019282752.1  AQP34953.1  Gamma  
Vibrio cholerae  WP_000433077.1  ADF80985.1  WP_076025069.1  Gamma  
Vibrio crassostreae  WP_048661363.1  WP_048663200.1  WP_048663203.1  Gamma  
Vibrio cyclitrophicus  WP_016791019.1  WP_016797283.1  WP_016797280.1  Gamma  
Vibrio genomosp. F10  WP_017040691.1  WP_065576635.1  WP_065576634.1  Gamma  
Vibrio harveyi CAIM1075  WP_050914487.1  WP_050937014.1  WP_050914489.1  Gamma  
Vibrio metoecus  WP_055052054.1  WP_055044314.1  WP_055052055.1  Gamma  
Vibrio mimicus  WP_000433076.1  WP_070382450.1  WP_000494954.1  Gamma  
Vibrio nigripulchritudo  WP_022552005.1  WP_022552020.1  WP_022552006.1  Gamma  
Vibrio parahaemolyticus  WP_020904316.1  WP_020904315.1  WP_020904314.1  Gamma  
Vibrio splendidus  WP_017087969.1  WP_017085935.1  WP_017085937.1  Gamma  
Vibrio tasmaniensis  WP_065106141.1  WP_041472952.1  WP_065113257.1  Gamma  
Vibrio vulnificus  WP_013572513.1  WP_013572512.1  WP_013572511.1  Gamma  
Mariprofundus ferrooxydans  WP_018294067.1  WP_026195384.1  WP_018294071.1  Zeta  
Zetaproteobacteria bacterium 
CG2_30_46_52  
OIP99107.1  OIP99141.1  OIQ00419.1  Zeta  
Zetaproteobacteria bacterium TAG-1  WP_038246546.1  WP_038246540.1  WP_038249350.1  Zeta  
 
Table S2. Bacterial strains containing homologs of R. etli CE3 WreQ, WreV and P. aeruginosa O6 WbpL.   
WreQ (YP_470339.1), WbpL (AAF23990.1) and WreV (YP_471773.1) were used individually as query sequences 
in BLAST searches against the non-redundant protein sequence (nr) database using the blastp algorithm. WreQ 
and WreV searches were performed following the same strategy as in Table S1. The WbpL BLAST search was 
performed by excluding Pseudomonadaceae and the maximum target sequences were set at 1000.  The 
resulting matches to WbpL all have E-values less than 7e-32. Strains containing homologs to the three genes are 
listed below, along with the accession numbers of the protein homologs and the phylogenetic affiliations of the 
strains.  Where strain numbers are absent, they can be found by investigating the gene accensions. 
 
Strain  WreQ accession  WbpL accession  WreV accession  Phylo  
Alphaproteobacteria bacterium  OFW83437.1  OFW83436.1  OFW84297.1  Alpha  
Azospirillum humicireducens  WP_063635086.1  WP_063635083.1  WP_063635087.1  Alpha  
Azospirillum lipoferum  WP_014248476.1  WP_012974782.1  WP_085556015.1  Alpha  
Azospirillum oryzae  WP_085089998.1  WP_085089995.1  WP_085089999.1  Alpha  
Azospirillum sp. B506  WP_042696170.1  WP_042696173.1  WP_042696169.1  Alpha  
Azospirillum thiophilum  WP_045580795.1  WP_045580792.1  WP_045580796.1  Alpha  
Devosia chinhatensis  WP_046103598.1  WP_046103597.1  WP_046103596.1  Alpha  
Devosia chinhatensis  WP_046103598.1  WP_046103597.1  WP_046103596.1  Alpha  
Devosia sp. 67-54  OJX19969.1  OJX19967.1  OJX19968.1  Alpha  
Devosia sp. Root105  WP_082528546.1  WP_055884710.1  WP_055872943.1  Alpha  
Haematospirillum jordaniae  WP_066132823.1  AMW34221.1  WP_066133023.1  Alpha  
Magnetospirillum gryphiswaldense  WP_041634754.1  WP_041634753.1  WP_052589129.1  Alpha  
Magnetospirillum gryphiswaldense  CDL00675.1  CDL00674.1  CDL00757.1  Alpha  
Magnetospirillum sp. XM-1  WP_068430147.1  CUW37957.1  WP_068430462.1  Alpha  
Mesorhizobium sp. YR577  WP_091914561.1  WP_091914110.1  WP_091914112.1  Alpha  
Mesorhizobium sp. YR577  WP_091914561.1  WP_091914110.1  WP_091914112.1  Alpha  
Rhizobium sp. Root149  WP_062557229.1  WP_062557228.1  WP_062557230.1  Alpha  
Rhodocista sp. MIMtkB3  WP_075773469.1  WP_075772476.1  WP_075769167.1  Alpha  
Rhodospirillaceae bacterium  OUX31398.1  OUX31399.1  OUX31397.1  Alpha  
Rhodospirillales bacterium  OHC75555.1  OHC75553.1  OHC75556.1  Alpha  
Terasakiella sp. PR1  WP_069186887.1  WP_069186886.1  WP_069186888.1  Alpha  
Thalassospira alkalitolerans  WP_085616563.1  WP_085615659.1  WP_085614765.1  Alpha  
Thalassospira mesophila  WP_085582449.1  WP_085578919.1  WP_085578921.1  Alpha  
Thalassospira profundimaris  WP_064788430.1  WP_008888595.1  WP_008888594.1  Alpha  
Thalassospira sp. MCCC  WP_085588244.1  WP_085590024.1  WP_085590155.1  Alpha  
Thalassospira sp. Nap_22  KXJ56428.1  KXJ54524.1  KXJ54525.1  Alpha  
Thalassospira sp. TSL5-1  WP_073955943.1  WP_073956208.1  WP_073955272.1  Alpha  
Thalassospira xiamenensis  WP_062958433.1  WP_062960508.1  WP_062960509.1  Alpha  
Azoarcus toluclasticus  WP_040394211.1  WP_051092234.1  WP_018988035.1  Beta  
Lautropia sp. SCN 70-15  ODT33269.1  ODT33266.1  ODT33268.1  Beta  
Methylibium sp. NZG  KNZ31778.1  KNZ31777.1  KNZ31776.1  Beta  
Aeromonas veronii  WP_005350303.1  WP_005338066.1  WP_005338065.1  Gamma  
Aquisalimonas asiatica  SEO80355.1  SEO80337.1  SEO80272.1  Gamma  
C. Tenderia electrophaga  ALP53219.1  ALP54791.1  ALP53220.1  Gamma  
C. Thiodiazotropha endoloripes  WP_068994608.1  WP_068994607.1  WP_068994639.1  Gamma  
Cellvibrio sp. PSBB006  WP_087465803.1  WP_087465802.1  WP_087465797.1  Gamma  
Crenothrix sp. D3  OTE95239.1  OTE95238.1  OTE95237.1  Gamma  
Ectothiorhodospira marina  WP_090255654.1  WP_090255652.1  WP_090250421.1  Gamma  
gamma proteobacterium IMCC2047  EGG98104.1  EGG99498.1  EGH00084.1  Gamma  
Halomonas utahensis  WP_077530405.1  WP_077530383.1  WP_077530382.1  Gamma  
Immundisolibacter cernigliae  WP_068803522.1  WP_068803523.1  WP_083214804.1  Gamma  
Legionella geestiana  WP_028385720.1  WP_051550994.1  WP_051550925.1  Gamma  
Legionella israelensis  WP_058500563.1  WP_058500543.1  WP_058500737.1  Gamma  
Marinobacter mobilis  WP_091817059.1  WP_091817062.1  WP_091817065.1  Gamma  
Methylobacter tundripaludum  WP_006890946.1  WP_006890945.1  WP_006890944.1  Gamma  
Methylomicrobium  WP_005371725.1  WP_005371723.1  WP_005371722.1  Gamma  
Methylomicrobium alcaliphilum  WP_014146586.1  WP_046061293.1  WP_046060910.1  Gamma  
Methylomicrobium buryatense  WP_017841410.1  WP_040575735.1  WP_017841407.1  Gamma  
Methylosarcina fibrata  WP_020562151.1  WP_020562152.1  WP_020562153.1  Gamma  
Methylosarcina lacus  WP_029646324.1  WP_024296937.1  WP_024296936.1  Gamma  
Methylovulum miyakonense  WP_019868468.1  WP_019868467.1  WP_019868466.1  Gamma  
Methylovulum psychrotolerans  WP_088618707.1  WP_088618706.1  WP_088618705.1  Gamma  
Microbulbifer variabilis  WP_020411331.1  WP_026304876.1  WP_020411328.1  Gamma  
Motiliproteus sp. MSK22-1  WP_076720080.1  WP_076720081.1  WP_076720083.1  Gamma  
Rheinheimera sp. SA_1  WP_082971652.1  WP_068063778.1  WP_082971650.1  Gamma  
Stenotrophomonas rhizophila  WP_061203702.1  KWW13329.1  WP_061203704.1  Gamma  
Thioalkalivibrio sp. AKL11  WP_083916429.1  WP_026288304.1  WP_018941009.1  Gamma  
Thioalkalivibrio sp. AKL17  WP_026289054.1  WP_018947748.1  WP_018945921.1  Gamma  
Thioalkalivibrio sp. ALJ15  WP_083925125.1  WP_020146293.1  WP_020146532.1  Gamma  
Thioalkalivibrio sp. ALJ2  WP_081616998.1  WP_018994651.1  WP_018994650.1  Gamma  
Thioalkalivibrio sp. ALR17-21  WP_024329946.1  WP_024329948.1  WP_024328922.1  Gamma  
Thiohalomonas denitrificans  WP_092998985.1  WP_092999077.1  WP_092992255.1  Gamma  
Deltaproteobacteria bacterium  OGQ52421.1  OGQ54831.1  OGQ57681.1  Delta  
 
 
Fig. S1. Complementation of the R. etli wreU::Km mutant strain CE566 with His6-wreU. Silver-stained SDS-PAGE 
(18% gel) of LPS samples from whole-cell lysates. Lanes: lane 1, CE3 (wild-type); lane 2, CE566 (wreU::Km); lane 
3, CE566/pLS22 (wreU::Km/His6-wreU). LPS I carries O antigen, whereas LPS II does not [1, 2]. 
 
 
Fig. S2. Complementation of the R. etli wreG::Tn5 mutant strain CE358 with wreG-His6. Silver-stained SDS-PAGE 
(18% gel) of LPS samples from whole-cell lysates. Lanes: lane 1, CE3 (wild-type); lane 2, CE358 (wreG::Tn5); lane 
3, CE358/pTL63 (wreG::Tn5/wreG-His6). 
 
 
 
 
 
Fig. S3.  (a) Topological model for R. etli CE3 WreU.  The shaded rectangle boxes represent transmembrane (TM) 
segments. The numbers indicate the amino acid positions of the boundary of each TM domain.  (b) Multiple 
sequence alignment of the R. etli CE3 WreU (YP_471772) with C. jejuni PglC (YP_002344517), the C-terminal 
domain (274-476 aa) of S. enterica WbaP (NP_461027) and the C-terminal domain (229-423) of A. hydrophila 
WecP (EU274663),  by use of the Clustal Omega program [3] (available on the World Wide Web at 
www.ebi.ac.uk/Tools/msa/clustalo/). Identical amino acids are highlighted in black and similar amino acids are 
highlighted in grey. 
 
  
Fig. S4. (a) Highlight of the possible Und-PP-KdgNAc-Man product present in Fig. 5.  (b) Suppression of R. etli 
wreQ::Tn5 mutant strain CE166 by introducing multiple copies of wreU or wreG gene.  Lanes: lane 1, CE3 (R. etli 
wild-type strain); lane 2, CE166 (wreQ::Tn5); lane 3, CE166/pLS22, strain CE166 harboring pLS22 plasmids 
expressing His6-WreU; lane 4, CE166/pTL63, strain CE166 harboring pTL63 plasmids expressing WreG-His6.  
Note that extra copies of wreG suppressed the deficiency in O-antigen amount (lane 4), whereas extra copies of 
wreU did not (lane 3).  Hypothesis 1 of Fig. 1(c) would have predicted suppression by multiple copies of wreU.  A 
probable explanation of the suppression is that higher concentrations of WreG compensate for its weaker 
catalysis when KdgNAc is the acceptor residue in the reaction instead of the preferred QuiNAc residue. 
 
 
Fig. S5.  The genomic locations of Rhizobium etli strain CE3 wreV, wreU, wreQ genes and their orthologs in 
Colwellia psychrerythraea strain 34H. wreV, wreU, wreQ and their orthologs are shown in green, red, blue 
respectively. Protein accession numbers: R. etli CE3 WreV (YP_471773), WreU  
(YP_471772), WreQ (YP_470339); C. psychrerythraea 34H WreV ortholog (WP_011041444), WreU ortholog 
(WP_011041440), WreQ ortholog (WP_011041439). 
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